NUVASIVE INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Net sales
Products
Services
Total net sales
Cost of sales (excluding below amortization of intangible assets):
Cost of sales
Products
Services
Total cost of sales
Gross profit
Operating expenses:
Selling, general and administrative
Research and development
Amortization of intangible assets
Litigation liability loss
Purchase of in-process research and development
Business transition (benefit) costs
Total operating expenses

Interest and other expense, net:
Interest income
Interest expense
Other expense, net
Total interest and other expense, net
Income (loss) before income taxes
Income tax (expense) benefit
Consolidated net income (loss)
Net income (loss) per share:
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted average shares outstanding:
Basic (in shares)
Diluted (in shares)

Comments